Paul Leatham, DPM
Foot & Ankle Surgery · Bellevue, OHNPI 1871014936
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (48.2%), education and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Mid-atlantic Surgical Systems, LLC at 28.1% of the total. Reporting peaked in 2021 at $3,826 and has fallen 86.9% since, to $500 in 2025.
Across 63 payments — averaging $127.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mid-atlantic Surgical Systems, LLC$2K
- Restor3d, Inc.$2K
- Stryker$1K
- DNE LLC$982
- Arthrex$655
- Smith+Nephew$145
- plus $572 from 7 others
What the payments were for
- Travel & lodging$3,88248%
- Food & beverage$1,92224%
- Education$2,25428%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mid-atlantic Surgical Systems, LLC | 5 | $2,266 |
| Restor3d, Inc. | 8 | $1,984 |
| Stryker | 27 | $1,454 |
| DNE LLC | 1 | $982 |
| Arthrex | 10 | $655 |
| Smith+Nephew | 2 | $145 |
| Amgen | 2 | $132 |
| Integra Lifesciences Corporation | 1 | $132 |
| Pylant Medical | 1 | $110 |
| Bioventus LLC | 3 | $88 |
| Medshape, Inc. | 1 | $64 |
| Vertex | 1 | $31 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,058 in reported general payments places this provider in the 75th percentile of 429 foot & ankle surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefadroxil | 44 | $303 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 27 | $198 |
| Ondansetron OdtOndansetron | 24 | $192 |
| Doxycycline Hyclate | 11 | $53 |
| Meloxicam | 28 | $48 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Bellevue
- Christopher HyerWorthington$4.7M
- Thomas LeePickerington$4M
- Jordan GrossmanAkron$2.5M
- Robert GorslineHilliard$1.4M
- Jonathan FeibelGahanna$1.4M
- Mark PrisselWorthington$1.2M
- Lee HladGahanna$440K
- Windy ColeKent$431K
- Elizabeth HewittGrove City$414K
- Dominic RizzoBlue Ash$303K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.